PIK3R3 and inflammatory bowel disease: PIK3R3(phosphoinositide-3-kinase regulatory subunit 3)has been reported to increase in Inflammatory bowel disease (IBD) patients, which indicates that PIK3R3 could be a therapeutic target for IBD (31).